-
1
المؤلفون: Virginia Valentine, Eric L. Johnson, Helena Rodbard, Leigh Perreault
المصدر: Advances in Therapy
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Combination therapy, medicine.medical_treatment, Review, Type 2 diabetes, Hypoglycemia, Weight Gain, Lower risk, Glucagon-like peptide-1 receptor agonists, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide 1, Internal medicine, medicine, Insulin, Humans, Hypoglycemic Agents, Pharmacology (medical), Glycemic, Glycated Hemoglobin, business.industry, Patient compliance, General Medicine, Liraglutide, Postprandial Period, medicine.disease, Combined Modality Therapy, Insulin, Long-Acting, Drug Combinations, Postprandial, Diabetes Mellitus, Type 2, Tolerability, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a38e5fecd9ee361b5982d5ec6fc4ca5Test
https://doi.org/10.1007/s12325-018-0868-9Test -
2
المؤلفون: Barnaby Hunt, Anna Sandberg, Samuel J. P. Malkin, Barrie Chubb, Pierre Johansen, Matthew Capehorn
المصدر: Advances in Therapy
مصطلحات موضوعية: Male, 030213 general clinical medicine, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Glucagon-Like Peptides, Pharmacy, Type 2 diabetes, Drug Administration Schedule, Glucagon-like peptide-1 receptor agonists, Diabetes Complications, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), health care economics and organizations, Aged, Original Research, Glycated Hemoglobin, business.industry, Liraglutide, Semaglutide, Body Weight, Diabetes, General Medicine, Middle Aged, medicine.disease, United Kingdom, Economic evaluation, Diabetes Mellitus, Type 2, 030220 oncology & carcinogenesis, Emergency medicine, Life expectancy, Female, Cost-effectiveness, Quality-Adjusted Life Years, business, Models, Econometric, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68704bdedb14460a06d2716bbd52416Test
https://pubmed.ncbi.nlm.nih.gov/32306244Test -
3
المؤلفون: Joseph M. Tibaldi
المصدر: Advances in Therapy
مصطلحات موضوعية: Weight loss, endocrine system diseases, Treatment outcome, Adamantane, Review, Type 2 diabetes, Endocrinology, Glycemic control, Piperidines, Glucagon-Like Peptide 1, Receptors, Glucagon, Pharmacology (medical), Medicine(all), Dipeptides, General Medicine, Incretin, Glucagon-like peptide-1, Patient preference, Clinical Practice, Treatment Outcome, Pyrazines, endocrine system, medicine.medical_specialty, Pharmacology toxicology, Linagliptin, Glucagon-Like Peptide-1 Receptor, Glucagon-like peptide-1 receptor agonists, Dipeptidyl peptidase-4 inhibitors, Internal medicine, medicine, Humans, Hypoglycemic Agents, Uracil, Intensive care medicine, Dipeptidyl-Peptidase IV Inhibitors, Venoms, business.industry, Sitagliptin Phosphate, nutritional and metabolic diseases, Liraglutide, Triazoles, medicine.disease, Diabetes Mellitus, Type 2, Purines, Quinazolines, Exenatide, Peptides, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3ce2525a91730da5bc161de08c9399Test
https://doi.org/10.1007/s12325-014-0100-5Test -
4
المؤلفون: Michael Horowitz, Christopher K. Rayner, Karen L. Jones
المساهمون: Horowitz, Michael, Rayner, Christopher K, Jones, Karen L
المصدر: Advances in Therapy. 30(2):81-101
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, endocrine system, endocrine system diseases, medicine.medical_treatment, exenatide, Type 2 diabetes, Pharmacology, Hypoglycemia, Glucagon-Like Peptide-1 Receptor, Lixisenatide, chemistry.chemical_compound, gastric emptying, Internal medicine, Type 2 diabetes mellitus, medicine, Receptors, Glucagon, Humans, Hypoglycemic Agents, incretin therapies, postprandial plasma glucose, Pharmacology (medical), glucagon-like peptide-1 receptor agonists, Glycated Hemoglobin, Medicine(all), liraglutide, Gastric emptying, Liraglutide, business.industry, Insulin, digestive, oral, and skin physiology, nutritional and metabolic diseases, General Medicine, medicine.disease, Postprandial, Endocrinology, hypoglycemia, Treatment Outcome, chemistry, Diabetes Mellitus, Type 2, business, Peptides, Exenatide, lixisenatide, pharmacokinetics, hormones, hormone substitutes, and hormone antagonists, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bf100b37016c9d5d7a1790d6c4c7c1Test